LTC Properties earnings rebound from pandemic lows
LTC Properties saw its net income soar a year after the pandemic caused serious interruptions to the real estate investment trust’s business model. On July 29, the Westlake Village-based REIT reported its net income for the second quarter of 2021 at $18.1 million, or 46 cents per share — an increase of more than 900% Read More →
Running shoe sales propel Deckers to profitable quarter
Goleta-based Deckers Brands started its 2021-22 fiscal year strong, reporting huge increases in earnings and revenue in quarterly results released after the markets closed July 29. The parent company of Ugg, Teva and other footwear brands delivered earnings of $48.1 million in the most recent quarter, or $1.71 per share, much better than the same Read More →
Citizens Business Bank to acquire Suncrest Bank
CVB Financial Corp., the parent company of Citizens Business Bank, announced July 27 that it will be merging with and absorbing Suncrest Bank. The deal is worth about $204 million, or $16.18 per Suncrest share. Through the merger, Citizens’ total assets will increase to about $17 billion, based on the most recent publicly available information Read More →
Teledyne shares rise after first earnings report since Flir acquisition
Teledyne Technologies crushed analysts’ expectations July 28, delivering revenue in the second quarter of 2021 that doubled its total from the same quarter a year ago, thanks in large part to its acquisition of Flir systems, an Oregon based company with significant operations in Goleta. Teledyne, a Thousand Oaks-based industrial and scientific conglomerate, generated $1.12 Read More →
Pacific Premier Bank back in black in Q2
Pacific Premier Bancorp, the holding company of Pacific Premier Bank, recorded almost $100 million in net income in the second quarter, a year after losing a similar amount, according to a quarterly report released July 27. The Irvine-based bank has seven branches in San Luis Obispo County and two in Santa Barbara County. Its net Read More →
Amgen to buy biotech startup TeneoBio
Amgen announced July 27 that it plans to buy a privately held Bay Area biotech company called TeneoBio in an all-cash deal worth as much as $2.5 billion. The deal is expected to close in the second half of this year and calls for Amgen to pay $900 million up front for all outstanding shares Read More →
Deal for new Santa Paula Hospital land ‘a long time in the making’
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
